Viz HCM vs iPredict Eye Screening
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your hospital or health system requires an FDA-cleared AI solution for the rapid and accurate detection of suspected Hypertrophic Cardiomyopathy directly from ECGs. This tool is ideal for organizations focused on streamlining cardiac care coordination, ensuring timely diagnosis and treatment by automatically directing patients to appropriate specialists.
View Viz HCM →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your primary care setting, clinic, or telemedicine service needs a versatile, AI-powered tool for quick and accurate screening of multiple retinal diseases, including AMD, Diabetic Retinopathy, and Glaucoma. This solution is best suited for broad patient populations, offering fast results and additional risk prediction for systemic conditions like stroke and heart attack.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz HCM | iPredict Eye Screening |
|---|---|---|
| Pricing | Subscription-based | Contact for pricing |
| Deployment | Cloud-based platform, integrated into hospital IT systems (EHR, PACS). | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM demonstrates superior usability with explicit positive user reviews highlighting its 'Great design, easy to use' interface and valuable mobile alerts for care coordination. It also received top ranking for 'User Satisfaction & Acceptance' in a Black Book survey. While iPredict Eye Screening emphasizes ease of operation and fast results, Viz HCM has external validation of its user experience.
Clinical Value
Viz HCMViz HCM offers strong, specific clinical validation for Hypertrophic Cardiomyopathy (HCM), demonstrating significant reduction in diagnosis time and extensive real-world evidence through numerous publications and studies. It is also the first and only FDA-cleared AI algorithm for HCM detection from standard 12-lead ECGs. While iPredict Eye Screening covers multiple ophthalmic conditions and systemic risk prediction with high accuracy, Viz HCM's demonstrated impact on a specific, critical disease pathway gives it a stronger edge in high-impact clinical value.
Pricing & Value
iPredict Eye ScreeningiPredict Eye Screening provides a more transparent pricing model with an estimated per-patient cost ($10-$20) and a clear percentage of Medicare/commercial payor reimbursement (20%-40%). Viz HCM, while mentioning CMS reimbursement codes, requires contacting the vendor for enterprise pricing, making its value proposition less immediately clear upfront.
Enterprise Readiness
Viz HCMViz HCM explicitly states it has a Business Associate Agreement (BAA) and is HIPAA compliant, with deployment integrated into hospital IT systems (EHR, PACS). It is also trusted by over 1700 hospitals. While iPredict Eye Screening states it is HIPAA compliant and FDA-cleared, its BAA status is not explicitly stated in the initial facts, and some search results suggest ongoing FDA clearance processes for specific modules, making Viz HCM's enterprise readiness more definitively established.
Innovation
iPredict Eye ScreeningiPredict Eye Screening offers a broader range of AI-powered screenings for multiple ophthalmic conditions (DR, AMD, Glaucoma) and uniquely provides an 'Online Health Risk Prediction System' for systemic diseases like stroke and heart attack. It has also secured multiple US patents in its domain. While Viz HCM's real-time care coordination for HCM is innovative, iPredict's wider scope of AI applications and systemic risk prediction demonstrates broader innovation.
Support & Docs
Viz HCMViz HCM provides comprehensive customer support, including a dedicated customer success team, a knowledge base with common questions and troubleshooting, and 24/7 on-call clinical specialists and implementation experts. iPredict Eye Screening offers contact information but lacks the detailed and extensive support structure described by Viz HCM.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | iPredict Eye Screening |
|---|---|---|
| Name | Viz HCM | iPredict Eye Screening |
| Company | Viz.ai | iHealthScreen |
| Primary Disease Focus | Hypertrophic Cardiomyopathy (HCM) | Age-related macular degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma; also risk prediction for stroke and heart attack |
| Key AI Functionality | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, real-time disease detection, mobile-based alerts, automated direction of patients, streamlines cardiac care coordination | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; Electronic Health Record (EHR) Solutions; AI-Based Telemedicine Service; Image Analyzer; Online Health Risk Prediction System |
| Target Specialties | Cardiology, Emergency Medicine, Hospital Medicine | Family Medicine, Internal Medicine, Ophthalmology |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and iPredict Eye Screening.